SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 541 filers reported holding SEAGEN INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,556,777,702 | +10.3% | 12,051,745 | +0.1% | 0.07% | +15.6% |
| Q2 2023 | $2,317,568,486 | +2.3% | 12,041,819 | +7.6% | 0.06% | -4.5% |
| Q1 2023 | $2,265,866,470 | +48.6% | 11,191,122 | -5.7% | 0.07% | +39.6% |
| Q4 2022 | $1,524,389,990 | -5.8% | 11,862,034 | +0.3% | 0.05% | -12.7% |
| Q3 2022 | $1,618,264,000 | -20.0% | 11,826,822 | +3.5% | 0.06% | -15.4% |
| Q2 2022 | $2,022,825,000 | +2.5% | 11,432,260 | -16.6% | 0.06% | +22.6% |
| Q1 2022 | $1,974,113,000 | -4.3% | 13,704,355 | +2.7% | 0.05% | 0.0% |
| Q4 2021 | $2,062,637,000 | -0.8% | 13,341,753 | +8.9% | 0.05% | -8.6% |
| Q3 2021 | $2,080,190,000 | +9.6% | 12,250,826 | +1.9% | 0.06% | +9.4% |
| Q2 2021 | $1,898,179,000 | +8.8% | 12,022,916 | -4.4% | 0.05% | +3.9% |
| Q1 2021 | $1,745,448,000 | -20.4% | 12,569,833 | +0.4% | 0.05% | -27.1% |
| Q4 2020 | $2,192,768,000 | – | 12,520,079 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |